pmc logo image
Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in Hepatitis C virus replicon
Sidhartha Hazari, Lizeth Taylor, Salima Haque, Robert F Garry, Sander Florman, Ronald Luftig, Frederic Regenstein, Srikanta Dash
Virol J. 2007; 4: 89. Published online 2007 September 18. doi: 10.1186/1743-422X-4-89
PMCID:
PMC2075494
Abstract Full Text PDF–1.0M
 Is Cited by the Following 5 Articles in this Archive:
Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication
Bret Poat, Sidhartha Hazari, Partha K Chandra, Feyza Gunduz, Xavier Alvarez, Luis A Balart, Robert F Garry, Srikanta Dash
Virol J. 2010; 7: 265. Published online 2010 October 12. doi: 10.1186/1743-422X-7-265
PMCID:
PMC2964675
Abstract Full Text PDF–1.9M
SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
Bret Poat, Sidhartha Hazari, Partha K. Chandra, Feyza Gunduz, Luis A. Balart, Xavier Alvarez, Srikanta Dash
PLoS One. 2010; 5(9): e13117. Published online 2010 September 30. doi: 10.1371/journal.pone.0013117
Correction in:
PLoS One. 2010; 5(11): 10.1371/annotation/ff8fe1fe-36ae-43fe-9350-8ba2f191331a.
PMCID:
PMC2948020
Abstract Full Text PDF–7.3M Correction
Polo-Like Kinase 1 Is Involved in Hepatitis C Virus Replication by Hyperphosphorylating NS5A
Yung-Chia Chen, Wen-Chi Su, Jing-Ying Huang, Ti-Chun Chao, King-Song Jeng, Keigo Machida, Michael M. C. Lai
J Virol. 2010 August; 84(16): 7983–7993. Published online 2010 June 9. doi: 10.1128/JVI.00068-10
PMCID:
PMC2916529
Abstract Full Text PDF–3.4M
Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway
Sidhartha Hazari, Partha K Chandra, Bret Poat, Sibnarayan Datta, Robert F Garry, Timothy P Foster, Gus Kousoulas, Takaji Wakita, Srikanta Dash
Virol J. 2010; 7: 36. Published online 2010 February 11. doi: 10.1186/1743-422X-7-36
PMCID:
PMC2831880
Abstract Full Text PDF–4.2M
Variants in Interferon-α Pathway Genes and Response to Pegylated-Interferon-α2a plus Ribavirin for Treatment of Chronic HCV Infection in the HALT-C Trial
Tania Mara Welzel, Timothy R. Morgan, Herbert L. Bonkovsky, Deepa Naishadham, Ruth M. Pfeiffer, Elizabeth C. Wright, Amy A. Hutchinson, Andrew T. Crenshaw, Arman Bashirova, Mary Carrington, Myhanh Dotrang, Richard K. Sterling, Karen L. Lindsay, Robert J. Fontana, William M. Lee, Adrian M. Di Bisceglie, Marc G. Ghany, David R. Gretch, Stephen J. Chanock, Raymond T. Chung, Thomas R. O’Brien, the HALT-C Trial Group
Hepatology. Author manuscript; available in PMC 2010 June 1.
Published in final edited form as: Hepatology. 2009 June; 49(6): 1847–1858. doi: 10.1002/hep.22877
PMCID:
PMC2692559
Abstract Full Text PDF–472K Supplementary Material
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk